3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Breast Neoplasms
10
Pain, Postoperative
7
Lung Neoplasms
4
Depression
4
Brain Neoplasms
4
Anxiety Disorders
4
Prostatic Neoplasms
3
Pain
3
Ovarian Neoplasms
3
Neoplasms
3
Colonic Neoplasms
3
Agnosia
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Fallopian Tube Neoplasms
2
Delirium
2
Colorectal Neoplasms
2
Warts
1
Uterine Cervical Neoplasms
1
Trauma, Nervous System
1
Thrombosis
1
Synovial Cyst
1
Stroke
1
Spondylosis
1
Spondylolisthesis
1
Spinal Stenosis
1
Sleep Initiation and Maintenance Disorders
1
Sigmoid Neoplasms
1
Sepsis
1
Interventions
plerixafor
1
gamma-Globulins
1
Saline Solution
1
Panzyga
1
Hizentra
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agammaglobulinemia
×
Saline Solution
×
1 year
×
Clear all
NCT05645107
2026-04-13
EXCELL
Grifols Therapeutics LLC
Phase 3
Recruiting
386 enrolled